Brian F. Chapin

The University of Texas MD Anderson Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor)”.

Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor)

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-006262

N/A

0.449DataRank · unranked

19 citations

Brian F. Chapin, Sonali Jindal, Fei Duan, Sreyashi Basu, Shalini S. Yadav +16 more

Costs and Complications After a Diagnosis of Prostate Cancer Treated With Time-Efficient Modalities: An Analysis of National Medicare Data

Practical Radiation Oncology(2020)10.1016/j.prro.2020.02.014

N/A

0.425DataRank · unranked

16 citations

Xiudong Lei, Grace L. Smith, Hubert Y. Pan, Kenneth R. Hess, Aileen B. Chen +8 more

Neoadjuvant apalutamide (APA) plus leuprolide (LHRHa) with or without abiraterone (AA) in localized high-risk prostate cancer (LHRPC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.5504

N/A

0DataRank · unranked

18 citations

Myrto Boukovala, Nicholas Spetsieris, Sijin Wen, Anh Hoang, Justin A. Weldon +15 more

Increased body mass index is associated with operative difficulty during robot‐assisted radical prostatectomy

BJUI Compass(2021)10.1002/bco2.110

N/A

0DataRank · unranked

10 citations

John W. Davis, Wendell H. Williams, Brian F. Chapin, John F. Ward, Curtis A. Pettaway +2 more

Oncologic outcomes among Black and White men with grade group 4 or 5 (Gleason score 8‐10) prostate cancer treated primarily by radical prostatectomy

Cancer(2021)10.1002/cncr.33419

N/A

0DataRank · unranked

14 citations

Jeffrey J. Tosoian, Chad A. Reichard, Debasish Sundi, Weranja Ranasinghe, Ridwan Alam +9 more

Archival single-cell genomics reveals persistent subclones during DCIS progression

Cell(2023)10.1016/j.cell.2023.07.024

N/A

0DataRank · unranked

56 citations

Tapsi Kumar, Junke Wang, Darlan Conterno Minussi, Emi Sei, Jianzhuo Li +27 more

HERCULES: A prostate cancer (PC) sequencing panel for parallel analysis of circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5036

N/A

0DataRank · unranked

0 citations

Jonathan D. Buckley, Dejerianne Ostrow, Jean‐Hugues Parmentier, Smruthi Maganti, Scott A. Mitchell +14 more

Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1

JU Open Plus(2024)10.1097/ju9.0000000000000137

N/A

0DataRank · unranked

7 citations

Alan H. Bryce, Maha Hussain, Neeraj Agarwal, Himisha Beltran, Matthew R. Cooperberg +33 more

Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2

JU Open Plus(2024)10.1097/ju9.0000000000000138

N/A

0DataRank · unranked

3 citations

E. David Crawford, Neeraj Agarwal, Maha Hussain, Himisha Beltran, Matthew R. Cooperberg +33 more

Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND Trial

European Urology(2025)10.1016/j.eururo.2025.07.006

N/A

0DataRank · unranked

24 citations

Bilal A. Siddiqui, Cara Haymaker, Bryan Fellman, Marina Nayeli Medina-Rosales, Tharakeswara Bathala +26 more

Integrating systemic therapy and metastasis-directed therapy in oligometastatic hormone-sensitive prostate cancer

Prostate Cancer and Prostatic Diseases(2025)10.1038/s41391-025-01041-z

N/A

0DataRank · unranked

2 citations

Jarey H. Wang, Brian F. Chapin, Ana M. Aparicio, Sumit K. Subudhi, Phuoc T. Tran +9 more

Combined genomic profiling of cell-free DNA (cfDNA) and circulating tumor cell DNA (ctcDNA) in S1802, a prospective phase 3 trial for metastatic prostate cancer (mHSPC).

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.e17111

N/A

0DataRank · unranked

1 citations

Jonathan D. Buckley, Scott A. Mitchell, Dejerianne Ostrow, Jean‐Hugues Parmentier, Samin Maleki Jahan +13 more

Randomized Phase 2 Trial of Presurgical Androgen Deprivation Therapy With or Without Axitinib in Prostate Cancer Presenting With Lymph Node Metastasis

European Urology Oncology(2025)10.1016/j.euo.2025.04.015

N/A

0DataRank · unranked

0 citations

Rebecca S. Tidwell, Brian F. Chapin, Deborah Harris, Miao Zhang, Louis L. Pisters +11 more

Influence of Geography on Prostate Cancer Treatment

International Journal of Radiation Oncology*Biology*Physics(2020)10.1016/j.ijrobp.2020.11.055

N/A

0DataRank · unranked

34 citations

Xiudong Lei, Grace L. Smith, Hubert Y. Pan, Karen E. Hoffman, Rachit Kumar +5 more